about
Tumor angiogenesis and vascular patterning: a mathematical modelVersican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4The Force at the Tip--Modelling Tension and Proliferation in Sprouting AngiogenesisFibulin-1 acts as a cofactor for the matrix metalloprotease ADAMTS-1The cleavage of semaphorin 3C induced by ADAMTS1 promotes cell migrationCarboxyl-modified single-wall carbon nanotubes improve bone tissue formation in vitro and repair in an in vivo rat modelPARP-1 regulates metastatic melanoma through modulation of vimentin-induced malignant transformation.Tumour angiogenesis is reduced in the Tc1 mouse model of Down's syndrome.ADAMTS proteases in vascular biology.ADAMTS1 contributes to the acquisition of an endothelial-like phenotype in plastic tumor cells.Cleavage of syndecan-4 by ADAMTS1 provokes defects in adhesion.Stroma-derived but not tumor ADAMTS1 is a main driver of tumor growth and metastasis.Endothelial cell dysfunction following prolonged activation of progesterone receptor.Evaluation of Tumor Vasculature Using a Syngeneic Tumor Model in Wild-Type and Genetically Modified Mice.NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL.ADAMTS1 protease is required for a balanced immune cell repertoire and tumour inflammatory response.Changes in tyrosine hydroxylase gene expression in mesencephalic catecholaminergic neurons of immature and adult male rats perinatally exposed to cannabinoidsThyroid hormone controls the expression of insulin-like growth factor I receptor gene at different levels in lung and heart of developing and adult ratsProgesterone regulates proliferation of endothelial cellsEndometrial endothelial cells express estrogen and progesterone receptors and exhibit a tissue specific response to angiogenic growth factorsInhibition of ADAMTS1 Expression by Lentiviral CRISPR/Cas9 Gene Editing Technology
P50
Q27339985-26E5F316-0913-4392-A439-E418D3096B97Q28207975-4EDC5C80-D56D-4D39-92B7-22C8194D2ACDQ28547082-CF435D7D-683C-4E56-90D5-FED7A1B7D688Q28586832-61DE961E-1B06-4EAC-B93E-4F3E3C9407E3Q33593917-4EAE260F-A7B0-43B3-90FF-ED81B061C203Q34198475-B5D78910-03AB-421A-B705-9E9A23539B4DQ34778528-0B5466F1-F72D-472C-9673-B39E48FCEB85Q36344071-FC727425-7D15-4192-83CB-C27902FC1B9AQ38362312-823DE276-83E4-4A1D-A1C8-A73FE2C86336Q39702470-3DDBE7E5-73ED-47E2-9A3D-73DC74FE92B2Q39942622-689438B4-D240-4D0F-AEEF-BC2FF6ADEC0CQ41610199-DFF36444-65C2-4E0F-B0CA-1C1BDD7B9984Q46632346-918BDFAE-0AA0-47E7-AE23-62916AE7E580Q47741562-C4357E5D-5044-4C1A-9146-9FE46D678771Q47930875-E045DCA2-4EC9-45D7-B6BC-C1B9EE551565Q64899990-892D7188-A628-4D6B-862A-8B7989D147C3Q72369226-546F710F-FEE2-45C0-8398-7B1AC3764022Q73106896-D5E6CF8F-7712-4894-BF5A-FDE269D99164Q77801041-AEBEEAB2-7AEE-4E2A-96AE-3F26C54EA940Q78183961-F307EB28-FC66-4D5E-B57C-C80E6FF4A1A3Q92972875-508F0C1B-ABD6-4202-AAC1-34A0FC96E7B5
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Juan Carlos Rodriguez-manzaneque
@ast
Juan Carlos Rodriguez-manzaneque
@en
Juan Carlos Rodriguez-manzaneque
@es
Juan Carlos Rodriguez-manzaneque
@nl
Juan Carlos Rodriguez-manzaneque
@sl
type
label
Juan Carlos Rodriguez-manzaneque
@ast
Juan Carlos Rodriguez-manzaneque
@en
Juan Carlos Rodriguez-manzaneque
@es
Juan Carlos Rodriguez-manzaneque
@nl
Juan Carlos Rodriguez-manzaneque
@sl
prefLabel
Juan Carlos Rodriguez-manzaneque
@ast
Juan Carlos Rodriguez-manzaneque
@en
Juan Carlos Rodriguez-manzaneque
@es
Juan Carlos Rodriguez-manzaneque
@nl
Juan Carlos Rodriguez-manzaneque
@sl
P1053
F-3899-2012
P106
P21
P31
P3829
P496
0000-0001-5951-7029